Review Special Issues

Human Mutations Affecting Reprogramming into Induced Pluripotent Stem Cells

  • The development of induced pluripotent stem cells (iPSCs) provides unprecedented opportunities for life sciences, drug discovery, and regenerative medicine. iPSCs have been generated from somatic cells in many patients with various genetic diseases carrying specific mutations. However, the efficiency of iPSC generation is quite low. Less than 1% of human primary somatic cells can usually turn into iPSCs. Previous studies have revealed that cellular signaling pathways, epigenetic status, and cellular senescence were major barriers to iPSC generation. Serendipitously in some cases, human mutations themselves affect the reprogramming efficiency of iPSC generation as well as cellular phenotypes recapitulating their disease symptoms. Mutations, which cause altered DNA repair (e.g., Ataxia-Telangiectasia, fanconi anemia and DNA Ligase IV (LIG4) syndrome), premature aging (e.g., Hutchinson–Gilford progeria syndrome and Néstor–Guillermo progeria syndrome), altered telomere homeostasis (e.g., dyskeratosis congenita), mitochondrial respiratory dysfunction, chromosomal abnormalities, and fibrodysplasia ossificans progressiva, have all been shown to affect the reprogramming efficiency of somatic cells to iPSCs. In this review, the effects of such mutations are summarized and the methods which have been employed to rescue efficient iPSC generation from mutant cells is discussed. Although the mutations affecting reprogramming processes are rare, these mutations have been invaluable to the elucidation of reprogramming mechanisms and to the development of improved reprogramming technologies.

    Citation: Yohei Hayashi. Human Mutations Affecting Reprogramming into Induced Pluripotent Stem Cells[J]. AIMS Cell and Tissue Engineering, 2017, 1(1): 31-46. doi: 10.3934/celltissue.2017.1.31

    Related Papers:

    [1] José Antonio Carrillo, Yingping Peng, Aneta Wróblewska-Kamińska . Relative entropy method for the relaxation limit of hydrodynamic models. Networks and Heterogeneous Media, 2020, 15(3): 369-387. doi: 10.3934/nhm.2020023
    [2] Elisabeth Logak, Isabelle Passat . An epidemic model with nonlocal diffusion on networks. Networks and Heterogeneous Media, 2016, 11(4): 693-719. doi: 10.3934/nhm.2016014
    [3] Hakima Bessaih, Yalchin Efendiev, Florin Maris . Homogenization of the evolution Stokes equation in a perforated domain with a stochastic Fourier boundary condition. Networks and Heterogeneous Media, 2015, 10(2): 343-367. doi: 10.3934/nhm.2015.10.343
    [4] Simone Göttlich, Stephan Martin, Thorsten Sickenberger . Time-continuous production networks with random breakdowns. Networks and Heterogeneous Media, 2011, 6(4): 695-714. doi: 10.3934/nhm.2011.6.695
    [5] Xia Li, Chuntian Wang, Hao Li, Andrea L. Bertozzi . A martingale formulation for stochastic compartmental susceptible-infected-recovered (SIR) models to analyze finite size effects in COVID-19 case studies. Networks and Heterogeneous Media, 2022, 17(3): 311-331. doi: 10.3934/nhm.2022009
    [6] Nurehemaiti Yiming . Asymptotic behavior of the solution of a stochastic clearing queueing system. Networks and Heterogeneous Media, 2025, 20(2): 590-624. doi: 10.3934/nhm.2025026
    [7] Mostafa Bendahmane . Analysis of a reaction-diffusion system modeling predator-prey with prey-taxis. Networks and Heterogeneous Media, 2008, 3(4): 863-879. doi: 10.3934/nhm.2008.3.863
    [8] Piotr Gwiazda, Karolina Kropielnicka, Anna Marciniak-Czochra . The Escalator Boxcar Train method for a system of age-structured equations. Networks and Heterogeneous Media, 2016, 11(1): 123-143. doi: 10.3934/nhm.2016.11.123
    [9] Arnaud Ducrot, Michel Langlais, Pierre Magal . Multiple travelling waves for an SI-epidemic model. Networks and Heterogeneous Media, 2013, 8(1): 171-190. doi: 10.3934/nhm.2013.8.171
    [10] Pierre Degond, Sophie Hecht, Nicolas Vauchelet . Incompressible limit of a continuum model of tissue growth for two cell populations. Networks and Heterogeneous Media, 2020, 15(1): 57-85. doi: 10.3934/nhm.2020003
  • The development of induced pluripotent stem cells (iPSCs) provides unprecedented opportunities for life sciences, drug discovery, and regenerative medicine. iPSCs have been generated from somatic cells in many patients with various genetic diseases carrying specific mutations. However, the efficiency of iPSC generation is quite low. Less than 1% of human primary somatic cells can usually turn into iPSCs. Previous studies have revealed that cellular signaling pathways, epigenetic status, and cellular senescence were major barriers to iPSC generation. Serendipitously in some cases, human mutations themselves affect the reprogramming efficiency of iPSC generation as well as cellular phenotypes recapitulating their disease symptoms. Mutations, which cause altered DNA repair (e.g., Ataxia-Telangiectasia, fanconi anemia and DNA Ligase IV (LIG4) syndrome), premature aging (e.g., Hutchinson–Gilford progeria syndrome and Néstor–Guillermo progeria syndrome), altered telomere homeostasis (e.g., dyskeratosis congenita), mitochondrial respiratory dysfunction, chromosomal abnormalities, and fibrodysplasia ossificans progressiva, have all been shown to affect the reprogramming efficiency of somatic cells to iPSCs. In this review, the effects of such mutations are summarized and the methods which have been employed to rescue efficient iPSC generation from mutant cells is discussed. Although the mutations affecting reprogramming processes are rare, these mutations have been invaluable to the elucidation of reprogramming mechanisms and to the development of improved reprogramming technologies.


    Airborne SARS-CoV-2 viruses spread between humans in particular through respiratory droplets [14,17] expelled during breathing, coughing or sneezing from an infectious person. Droplets resulting from coughing or sneezing can infect a target person by entering into the respiratory mucosa. These droplets can be separated in coarse (>5 μm) and fine (5 μm) fractions. Although large particles can be respired and reach alveolar tissues [7], they usually fall to the ground quickly within 1–2 m [28,29]. However, smaller droplets (aerosols) remain suspended in the air for much longer periods of time, having been found to be infectious even after 12 h [15]. This route most likely leads to major spreading at home, work, hospitals and in urgent care medical units [20]. Indeed, indoor space is a major SARS-CoV-2 infection risk [20], as the virus can be transmitted via speech droplets [3]. Aerosol particles are able to travel hundreds of meters or more [31]. Furthermore, fine particles were found to contain 8.8 times more viral copies than coarse particles [18]. Yet, precisely quantifying the infectivity due to aerosols transmission remains difficult: it is hard to measure the droplets despite recent efforts [3], and the step from droplet dispersion to human contamination requires an assessment of the efficiency of infection. To get around these difficulties, data was obtained in ferrets [12], although it still remained difficult to extrapolate these aerosol transmission measurements to the human scale. In ferrets, sneezing increases the number of small droplets [12] and the majority of particles generated during sneezing were <5μm. For example, exhaled aerosol particles from infected or naive ferrets during normal breathing (for 30 min) or sneezing (for 5 min) both lead to around 5000 droplets produced. In influenza, human study participants exhaled between 3.2 and 20 virus RNA copies per minute [9], which is assumed to be of similar magnitude for SARS-CoV-2. The motion of aerosolized particles is well approximated as a diffusion process, with a size-dependent diffusion coefficient ranging from D=104m2/s, for a size around 0.1 μm to D=107m2/s, for 5μm [25].

    Here, we compute the time it takes for a susceptible person to get infected when in close proximity to an infected person. By susceptible, we assume that the person has not been exposed before and that their immune system is naive regarding the pathogen. We explore how this transmission depends on the number of viral particles, air transportation parameters and the distance between two persons. We adopt the terminology clinicians use for airborne infectious diseases throughout this paper, meaning that an aerosol or aerosolized particle refers to an airborne drop of liquid smaller than 10μm and a particle is equivalent to a virion [27,30]. Influenza A has a 50% human infectious dose (HID50) of around 1000–2000 viral particles [1,19,32]. The HID50 is not known for SARS-CoV-2, but medical experts estimate it to be lower than for Influenza A, between hundreds and thousands of viral particles [22,23]. We therefore model infection by counting the number of viral particles a susceptible person inhaled until the threshold number for infection is reached. From the above, we set this threshold to be at 100 particles, the lowest reasonable number for SARS-CoV-2 (see Section 4.2). We estimate the probability and the mean time to infection (i.e., until the threshold is reached) when the infectious and susceptible person are placed in the same room or outside using diffusion modeling and numerical simulations of aerosols. We evaluate the role of wearing a mask [13] in several different scenarios, including regular respiration cycles (exhalation) and coughing. While surgical masks reduce viral copy numbers in the coarse droplet fraction by a factor of 25, we focus here on the fine fraction, where they reduce the viral aerosol load only by a factor of 2.8 [18]. Indeed, there are much more efficient masks or respirators available [10], but our aim is to show the effects for these simple masks. Finally, we explore the sensitivity of several key parameters such as the diffusion coefficient or the viral copy number threshold required for infection. In summary, we found that being in the same room as a non-coughing infectious person for less than 100 min does not lead to infection, while being exposed to a coughing person without protection can lead to infection within minutes. We did not investigate the time to infection when the infected person is talking, due to the variability in aerosolized particle production during speech [2,4,11] (however, we speculate that it would be similar to the coughing case). We conclude that wearing a mask can strongly suppress the propagation of infection via the small aerosol particle route.

    We model viral diffusion and infection as follows: an infected person is positioned at a distance d from a susceptible person, either in a 3×2×2m room or outside (Figure 1a). We address the difference in the release of free diffusing aerosols during regular respiration (exhalation) and sneezing or coughing, by changing the initial distribution and increasing the number of droplets (see Section 4.1): coughing is modeled by releasing 104 viral particles instantaneously with a rate in a range between 30 s to 5 min [33]. Each viral particle is contained in their own aerosolized particle of 0.1 μm size [16,33]. The full particle load is randomly and uniformly distributed in a sphere of 1 m diameter directly in front of the infected person's head.

    Figure 1.  Simulations of infection by diffusing aerosols: infection time distribution when an infected person is breathing only. (a) 3D schematic representation of a closed room containing an infected (red) and a susceptible (blue) person separated by a variable distance d. The room contains two windows which can be either open or closed, and a possible drift of air between the windows. (b) 2D schematic projection of (a). Room and window dimensions are displayed in the schematics. (c) Distribution of time of infection for distances d = 0.5, 1, 1.5, 2 and 2.5 m and the following scenarios: indoors with windows closed (blue), indoors with open windows and no drift (orange), indoors with open windows and a drift (green), outdoors without drift (red), and outdoors with drift (purple). (d) Mean infection time for the different scenarios. Missing bars indicate scenarios in which at least one realization had an infection time beyond 12 h. Error bars indicate the standard deviation of the time distribution.

    We also investigated breathing without coughing (in e.g., asymptomatic cases). In this case, we use a production of 10 particles per minute at the location of the infected person's head. This value was motivated from Fabian et al., [9], who found between 3 and 20 viral RNA copies per minute in patients infected with influenza A, and from Milton et al., [18], who found a median of 560 viral RNA copies in 30 min of sampling. The susceptible person is modeled as an absorbing sphere of 10 cm radius around the person's head. This accounts for the breathed-in volume of air during inhalation.

    Infection occurs when a threshold number of 100 viral particles are inhaled by the susceptible person, accounting for the fact that the independent action hypothesis likely does not hold for SARS-CoV-2 [26].

    In the indoors case, the room has a pair of windows in the centers of the long walls (opposite each other) that can either be open or closed. When the windows are open (where they act as absorbing surfaces), there can be a small draft (resulting in a drift of 1 mm/s) in the volume between the windows or no draft. In the outdoors case, it is either wind-still, or the same drift is applied throughout the domain. In our simulations, these cases were differentiated by implementing different boundary conditions. Finally, the susceptible person can wear a mask, in which case only one in 2.8 particles is absorbed on average [18].

    We first study the time to infection based on diffusing aerosols in a closed room, containing a susceptible person separated by a distance d from an infected person (Figure 1a, b). We run simulations to obtain the distribution of infection times to reach a cumulative infection threshold T=100 of aerosol particles inhaled by the susceptible person (using 100 realizations). As we vary the distance d (Figure 1c), we find that the mean time of infection increases drastically: For d=0.5,1, and 2m, we found a mean time of 95±7 min, 212±10 min, and 362±15 min (mean and standard deviation, respectively). Open windows alone, or even being outside, have no effect at small distances (for d1m) and an increasing but still small effect at larger distances (d1m) on these time scales (Figure 1c, d). A small drift of 1mm/s perpendicular to the axis connecting the two persons leads to an increase of the time of infection to around 381±35 min, a four-fold increase at a distance of d=0.5m. For larger distances, we do not show the infection time because it is beyond our simulation time limit of 12 h. Hence, in our model of diffusing aerosols generated by periodic breathing with 10 viral particles released per minute, we found that the infection threshold of 100 absorbed particles is reached in around 1.5 h. Open windows without a drift does not change this timescale substantially, but ventilation in form of a drift does.

    We derived the mathematical expression for the infection time as a function of distance (see Eq (4.11)). This provides a good fit to the simulation results for the outdoor case (Figure S4).

    Next we evaluate the time to infection of a susceptible person using the same spatial configuration as before Figure 2a, b. Here, the infected person coughs every 5 min. We disregard the production of viral particles due to breathing here because the added particle influx is minuscule compared to the effects of coughing. The time to infection reduces drastically compared to breathing alone, as coughing leads to the instantaneous release of 104 particles in front of the infected person. Our results show that the distribution for the times of infection are peaked around the mean: at a distance of d=0.5m, the mean time to infection is 16±1 min indoors and outdoors (regardless of the state of the windows) without a drift. This rises to 26±2 min when there is a drift. At larger distances, a small drift more than triples the time to infection, which highlights the importance of distancing even when there is appropriate ventilation. Coughing at 30 s intervals shortens the time to infection by roughly a third (Figure 3). Note that we assumed that the infected person is facing away from the susceptible person when coughing (light red shaded region in Figure 1a, b). As before, we do not show the mean time to infection if it is longer than 12 h.

    Figure 2.  Infection times when an infected person is coughing once every 5 min. (a) 3D schematic representation of a closed room containing an infected (red) and a susceptible (blue) person separated by a variable distance d. The spherical volume in which 104 coughed particles are dispersed instantly is shaded red. As before, the room contains two windows which can be either open or closed with a possible drift between the windows. (b) Overhead view of (a). Room and window dimensions are displayed in the schematics. (c) Distribution of time of infection for distances d=0.5,1,1.5,2 and 2.5 m and the following scenarios: Indoors with windows closed (blue), indoors with open windows and no drift (orange), indoors with open windows and a drift (green), outdoors without drift (red), and outdoors with drift (purple). (d) Mean infection times for all scenarios. Missing bars indicate scenarios in which at least one realization had an infection time beyond 12 h. Error bars indicate the standard deviation of the time distribution.
    Figure 3.  Influence of the cough interval. Mean time to infection for two different cough intervals, 5 min (blue) and 30 s (orange), and increasing distances d between the infected and susceptible persons. Error bars indicate the standard deviation of the time distribution.

    We derived an analytical formula for the flux of viral particles being absorbed by the susceptible person Eq (4.9). Integrating this flux numerically and finding the time at which the cumulative number of absorbed particles crosses the infection threshold allows a direct comparison with our simulation results (Figure 4).

    Figure 4.  Mean infection time as a function of distance for a single cough. The mean infection time as a function of distance d from simulations (crosses) for the indoor case with windows closed (blue) and the outdoor case without any drift (orange) when the infected person is coughing once. Error bars indicate the standard deviation. The solid line shows τinf from Eq (4.12), together with the crossover time τc (dashed black line). Note that the threshold is set to two particles here (see Section 4.3).

    We also looked at the importance of the direction of the air movement. Figure 2 shows the mean time to infection when air moves perpendicular to the line connecting the infected and the susceptible person. When the drift is applied parallel to this line (i.e., particles are blown from the infected person towards the susceptible person), the mean time to infection is reduced such that infection occurs at the half-hour mark even at a distance of d=2.5m (Figure S1). When the wind direction is antiparallel, infection is not occurring within any reasonable time frame (Figure 5).

    Figure 5.  Influence of the direction of air movement. The mean time to infection as a function of distance and air movement direction for an infected person coughing in a room with open windows. (a) The light blue arrow indicates the direction of air movement/ventilation between the two windows. The direction of infection between the infected person (red circle) and the susceptible person (blue circle) can be perpendicular (left panel), parallel (middle panel) and antiparallel (right panel) to the direction of air movement. The shaded circle indicates the volume in which viral particles appear during coughing. (b) Distribution of time to infection for distances d=0.5,1,1.5,2 and 2.5 m and the scenarios: perpendicular (blue), parallel (orange) and antiparallel (green). (c) Mean infection time for the different scenarios. Missing bars indicate scenarios in which at least one realization had an infection time beyond 12 h. Error bars indicate the standard deviation of the time distribution.

    Next, we evaluate the effect of a susceptible person wearing a mask on the time to infection. Surgical masks reduce the viral copy numbers in the fine diffusing fraction by a factor of 2.8 in viral aerosols [18]. We run similar simulations as above, where we model a mask by randomly counting only one in 2.8 particles that arrive at the susceptible person. When the infected person is breathing only (Figure 6), the mask increases the time to infection consistently by more than an hour for all distances. At d=0.5 m, the time to infection more than doubles, from 95±8 min to 200±14 min. When the infected person is coughing, the effect of the mask is lessened, but still adds eight to 28 min depending on the distance.

    Figure 6.  Effect of wearing a mask. (a) Mean infection times for various distances d = 0.5, 1, 1.5, 2 and 2.5 m (indoors with windows closed), with and without mask when the infected person is breathing only. The mask rejects on average 2.8 particles for every single particle it lets past. (b) Mean infection times for the same scenario as in (a), except that the infected person is coughing every 5 min. Error bars indicate the standard deviation of the time distribution.

    Due to the large uncertainty in the value of key parameters such as the diffusion coefficient or the threshold of infection, we change their values and explore the consequence on the mean time of infection. Halving the threshold number of particles from 100 to 50 reduces the time to infection by only 4–13 min when the infected person is coughing, depending on the distance (Figure 7a; see Figure S3 for the breathing case). Increasing the threshold by an order of magnitude, from 100 to 1000 only roughly doubles the time to infection. Hence, the dependence of time to infection on the threshold is non-linear, as predicted by Eq (4.11) in the supplementary. Conversely, the value of diffusion coefficient has a significant effect: an increase from 105m2/s to 104m2/s decreases the infection time at d=1 m from 230 min to 39 min. Finally, we vary the number of particles emitted during coughing from 5000 to 20000. At a distance of d=1 m, this leads to a decrease of infection time from 49 min to 32 min. Therefore, wide variations in both the threshold number and the number of particles emitted during coughing have a comparatively small effect on the time to infection. In contrast, the diffusion determines the timescale, so its value does directly scale the time to infection. Even though these parameters are not known, the trends described above are still valid, if not the exact values of the time to infection.

    Figure 7.  Sensitivity of the mean infection time to the threshold and diffusion coefficient. The mean infection time is estimated for an infected person coughing every 5 min in a room with windows closed. (a) Mean infection time for different values of the infection threshold count. (b) Influence of the diffusion coefficient. (c) Mean infection time versus the particle count contained in a cough. Error bars indicate the standard deviation of the time distribution.

    Here, we presented a model for airborne viral propagation based on diffusion of aerosols between an infectious and susceptible person [14,17]. We focused on small aerosol particles (<5μm) because they can deeply penetrate into the respiratory tract [28,29], leading to a high probability of infection. A number of parameters used in our simulations, in particular the number of viral particles required for an infection, the number of viral particles emitted during breathing or coughing and the aerosol diffusion coefficient, are not well known and also would be difficult to estimate experimentally. We therefore based their values on other airborne viral illnesses (see Sections 4.1 and 4.2). To validate our results, we performed a series of parameter sensitivity studies that show that the trends we observe do not strongly depend on the exact parameter values (Figure 7).

    The most striking result of the present study is the difference in time to infection between the cases when the infected person is breathing normally (e.g., during an asymptomatic infection) to when the infected person is coughing: A susceptible person needs to spend a considerable amount of time in close proximity to an infected person who is not coughing. This picture changes immediately when the infected person is coughing (Table 1). While we did not look at speaking specifically, we can assume that if the infected person is talking (even if they are not coughing), the picture will be similar to the coughing case. According to the published literature, the accumulated number of aerosol particles emitted while speaking over a 5 min interval is similar to our assumption of 104 particles emitted all at once [2,4,11].

    Table 1.  Summary of the simulated time to infection at d=1m. The values shown are the time to infection in minutes at the CDC-recommended inter-person distance of 1 m for all cases we considered in our simulations.
    Breathing Coughing
    Indoors, closed windows 212 (369 with mask) 39 (55 with mask)
    Indoors, open windows 220 39
    Indoors, drift >12 h 166
    Outdoors, no drift 248 40
    Outdoors, drift >12 h 409

     | Show Table
    DownLoad: CSV

    Coughing three times (once every five min) leads to infection in 15 min. Coughing every 30 s roughly halves this time, but does not shorten it by a factor of 10 as could be naively assumed. This is because we assume that the room is completely uncontaminated at the start of the simulation, without any viral particles present, and it takes time for aerosolized viral particles to disperse independently of the coughing frequency. Therefore, this is analogous to a situation where at time zero, the infected person enters the room and starts to cough. While we did not address the reverse situation where the susceptible person enters a room that already contains an infected person (and viral particles have had time to disperse), we can infer that, in this case, infection will occur much quicker. In a modeling study of influenza transmission, Atkinson and Wein found that a cough has a probability of roughly 25% to transmit the disease in a household setting [5,29], which compares well to our findings.

    Distance. Our results suggest that the time to infection increases roughly linearly with distance. Apart from coughing/breathing and ventilation, this is the parameter with the most influence on the infection time. Our results are consistent with the UK Scientific Advisory Group for Emergencies' report on the transmission risk of SARS-CoV-2, stating that a 1m separation carries 2–10 times the risk compared to a 2m separation [8]. A recent meta-analysis of multiple different studies (also involving SARS-CoV-1 and MERS) found that the risk of infection approximately halved for every additional meter of separation [6].

    Masks. We found that wearing a mask increases the time it takes to get infected when breathing only, which reinforces that consistent mask wearing reduces asymptomatic transmission (Figure 6, Table 1). It also increases the time to infection in the coughing case, although the effect is much smaller. Note that we only look at the small aerosol particle fraction, for which a mask is less efficient. We assume that the infectious person is coughing in a direction away from the susceptible person, which prevents spread via large droplets. Our results here are in line with recent findings that masks can stagger the pandemic over longer times, thereby preventing the saturation of intensive care units in hospitals [21].

    Ventilation. We compared the time to infection indoors when windows are closed to when they are open (Figures 1 and 2; Table 1). In the absence of ventilation (i.e., a drift), the role of a window is to prevent the accumulation of viral particles in the room by creating a region that effectively absorbs particles. However, we find this is not enough to substantially affect the time to infection. If, in addition, there is ventilation (even a small drift is sufficient), the time to infection increases markedly. This assumes that this air movement is in any direction but from the infected to the susceptible person. In that case, the time to infection is reduced considerably (Figure S1). Therefore, we can conclude that ventilation is a good prevention strategy, but care must be taken about the direction of air movement.

    Infection threshold number. The threshold number of particles required for an infection had only little effect on the infection time (Figure 7). This is due to waves of large numbers of particles being released with each cough event. In the regimes relevant for infection, the time to infection is then determined more by when the next wave of particles reaches the susceptible person rather than by how many are absorbed.

    In summary, we believe that the present diffusion-based simulation method yields relevant insights into the relative effects of different scenarios, and also provides a good indication of the magnitude of the time to infection. However, we stress that since the simulation results are dependent on parameter values that are not well known and had to be inferred, the exact time to infection predicted by the simulations should not be taken at face value. Nevertheless, as we showed, the trends we present are valid and are in line with other findings in the literature and public guidance.

    The microscopic diffusion coefficient of aerosolized particles is estimated using the Einstein-Kolmogorov formula and is below 1010m2/s. However, the dominant process in this case is not microscopic diffusion, but turbulent diffusion, where the effective diffusivity is increased to D=104m2/s. To simulate the spread of aerosolized viral particles, we use Brownian motion. The position Xi of each particle i satisfies the Smoluchowski limit of the Langevin equation [24]

    dXi=F(Xi)dt+2DdWi, (4.1)

    where F(x) specifies a possible drift due to air movement (open windows in the indoor case, or wind in the outdoor case), D is the diffusion coefficient of the aerosolized particle, W is a Wiener process. We discretize this equation using the Euler-Maruyama algorithm (forward time stepping) using custom-written code.

    Interaction with various surfaces is accounted for by various boundary conditions: In the indoors case, particles are reflected by walls, floor and ceiling, placed at the x,y,z=0 m and x,y=3 m and z=2 m positions. Windows are located at the y=0 m and y=3 m walls, with the extents 0.5m<z<1.5m and 1m<x<2m. Note that we disregard particle deposition at surfaces.

    If windows are open, a particle's trajectory is terminated once it crosses the window boundary (i.e., windows represent absorbing boundaries). In the outdoors case, only the floor at z=0m is reflecting, and we restrict our computational domain to a spherical domain with a radius of 10m. The optional drift is applied with F([x,y,z])ey either throughout the domain in the outdoors case or limited to the region 0.5m<z<1.5m and 1m<x<2m in the indoors case (i.e., directly between the windows). While the drift is likely to be stronger outdoors than when two windows are open indoors depending on weather and wind, we nevertheless opted to input the same drift strength in both cases. This was done to be able to have comparable scenarios, but will likely underestimate the mean infection time outdoors.

    In the case of breathing, the infected person is modelled by a point source that randomly emits particles with an average rate of 10 particles per minute. In the case of coughing to include effects from jets and puffs, the source of particles is a spherical volume directly in front of the infected person's head, facing away from the susceptible person and of 1m diameter, in which 104 particles are randomly placed every 5 min (in the case of coughing).

    The susceptible person is modelled as an absorbing spherical surface of 10 cm radius, a distance d away from the infected person. When a threshold number of particles has been absorbed by the sphere, the time of this event is recorded as the time of infection and the simulation terminated. A summary of all simulation parameters can be found in Table 2.

    Table 2.  Parameter summary. The values of all parameters used throughout all our simulations, unless explicitly stated otherwise in the text. Particle emission rate and coughing parameters are only used in the breathing-only and coughing cases, respectively.
    All cases
    Effective turbulent diffusivity D 104m2/s
    Inter-person distance d 0.52.5m
    Room size (indoors only) W×L×H 3×2×2m
    Window size W×H 1×1m
    Absorbing sphere diameter 20cm
    Drift 0 or 1mm/s
    Infection threshold T 100particles
    Maximum simulation time 12h
    Breathing only
    Particle emission rate 10particles/min
    Coughing
    Number of particles per cough 104
    Cough interval 5min
    Cough volume diameter 1m

     | Show Table
    DownLoad: CSV

    Our approach, while well-suited to the simulation of the spreading of aerosolized particles, also has limitations when applied to the spread of viral infections:

    Small versus large droplets: We only consider the spreading of small particles/droplets. Larger droplets (above 5μm) are not well described by the diffusion approach. However, these particles will also reasonably quickly drift to the ground due to gravity. Therefore, they would modify our results only for small distances between susceptible and infected persons, decreasing the time to infection.

    Diffusion coefficient: The diffusion coefficient of the particles is determined by their size. While aerosolized particles have a distribution of sizes, we make the simplification that particles have a fixed size and hence a fixed diffusion coefficient. Since the diffusion coefficient essentially sets the timescale of infection, the value of the diffusion coefficient influences the time to infection. Therefore, the absolute values of the mean time to infection directly depend on the diffusion coefficient, but the qualitative trends (such as the effect of wearing a mask or ventilation) are independent of it. Since the diffusion coefficient becomes larger for smaller particles, the infection dynamics is dominated by the smallest infectious particles. We chose the size (and hence the diffusion coefficient) to be consistent with aerosol droplets containing one viral particle each on average.

    Threshold for infection and coughing: Some parameters are not well-known or need to be inferred from other airborne viral illnesses such as influenza. The threshold number of particles required for an infection is not known for SARS-CoV-2, but medical experts estimate it to be between hundreds and thousands of particles [22,23]. We decided to use a threshold number of 100 particles, the lowest reasonable number. This ensures that our model under-estimates rather than over-estimates the mean time to infection. Furthermore, the mean time to infection is surprisingly insensitive to the exact threshold (Figure 7a). The average number of particles emitted during coughing is also not well-known, but similar to the threshold number, the time to infection is not strongly dependent to the exact value (Figure 7c).

    Walls: Here, walls, the floor, and the ceiling are reflective for droplets, but they could also simply stick to surfaces. Removing them would lead to less droplet load, making the mean time to infection longer. However, comparing our indoors and outdoors simulations, this effect is small. We disregard any furniture, or the bodies of the infected and susceptible people, which would likely only have a small effect on the mean time to infection. This is because the threshold is reached by the fastest set of particles that moves directly toward the respiratory tracks.

    Drift: In the scenarios that include a drift, we assumed a small drift strength representing light air movement. Stronger air movement will more strongly affect the mean time to infection, but the direction of this effect depends on the exact setting (see supplementary Figure S1). We assumed the same drift strength for our indoor and outdoor scenarios. Depending on wind and weather, and for a perpendicular wind direction, this likely understates the drift in the outdoor case; hence, our results likely underestimate the mean infection time. In the case of a parallel wind, this depends strongly on its direction (parallel versus antiparallel, see Figure S1).

    We use the theory of diffusion to estimate the flux of droplets to the nose entrance of a susceptible person: after N0 droplets are instantaneously released following breathing, sneezing, or coughing, they diffuse into the surrounding air. We neglect any surrounding surfaces such as floors and walls and, as above, assume that infection occurs when the number of droplets reaches a given threshold T. The spatial distribution of droplets satisfies the diffusion equation

    p(x,t|x0)t=DΔp(x,t|x0)forx,x0R3,p0(x,t|y)=p0(x,t|x0)=N0δ(xx0)forx,x0R3p0(x,t|y)=0forxΩap(x,t|x0)0forx, (4.2)

    where x0 is the position of the source (i.e., the infected person). The flux of droplets on an absorbing surface near the face (Ωa) of a susceptible person is given by

    Φ(t)=DΩapn(x,t|x0)dSx (4.3)

    and the cumulative number of particles absorbed is

    F(t)=t0Φ(s)ds. (4.4)

    When the source (i.e., the infectious person) is at x and the target (i.e., the susceptible person) is located at position y, the distribution is given by

    p(x,t|y)=N0(4πDt)3/2exp(|xy|24Dt). (4.5)

    By neglecting the variation of the flux on the surface Ωa when the distance between the two faces is large, δ=|xy|1, the flux can be approximated by

    Φ(t)δN0(4πDt)3/2(2t)|Ωa|exp(δ24Dt). (4.6)

    Figure 8 shows the absorbed flux of viral particles as a function of time for different distances. Note the sharp spike in the flux for small distances, which is smoothened for larger distances.

    Figure 8.  Analytical absorbed flux for a single cough at t=0. Flux of particles absorbed by the susceptible person for different inter-person distances δ from Eq (4.3). The infected person coughs once, releasing 10,000 particles instantaneously at t=0. Here, the diffusion coefficient is set to D=104m2/s.

    The number of inhaled particles over time is then

    F(t)=δ|Ωa|t0N0(4πDs)3/2(2s)exp(δ24Ds)ds=N0|Ωa|2π3/21δ2g(4Dtδ2), (4.7)

    where g(x)=x01s5/2exp(1s)ds. Note that for short times 4Dtδ21, g(4Dtδ2)δ4Dtexp(δ24Dt) and thus

    F(tδ24D)=N0|Ωa|2π3/21δ4Dtexp(δ24Dt). (4.8)

    For long times, g approaches a constant given by g(4Dtδ2)=π/2 (Figure S4). The relevant time scale here is τc=δ24D, which at δ=1m and with D=104m2/s, τc=2500s42 min. The time of infection τinf is achieved when the total number of inhaled particle reaches the threshold Tinf:

    τinf=inf{t>0s.t.F(t)=T}. (4.9)

    Note that the probability of an infection occurring earlier than τinf can be defined by

    Pr{t<τinf}=F(t)F(T)=g(4Dtδ2)g(4DTδ2). (4.10)

    When infection occurs in the time regime before τc, we can invert relation (4.8) to get Tδ22π3/2N0|Ωa|=δ4Dtexp(δ24Dt) leading to

    δ24Dt=W0(2[Tδ22π3/2N0|Ωa|]2), (4.11)

    where W0 is the positive branch of the Lambert function. With W0(x)=ln(x)ln(lnx)+o(1), it can be approximated as

    τinfδ2D[ln(Tδ2(2π)3/2N0|Ωa|)]1 (4.12)

    Interestingly, relation Eq (4.12) shows that the infection time depends weakly on the threshold (as the reciprocal of the logarithm). Expression (4.12) matches well with data from stochastic simulations for infection times τinf<τc for a single cough (Figure 4). Note that we changed the threshold to 2 particles for this, to push the infection time below the τc threshold for small distances.

    We can extend the previous analysis for repetitive expulsion of particles (i.e., coughing). At the point source, we periodically inject a load of particles. In this case, we can define the elementary injection time Δtinj (Δtbreath or Δtcough) leading to the following condition at the source:

    p0(x,t|y)=k>0N0δ(xy)δ(tkΔtinj), (4.13)

    where N0 is the number of viral particles expelled by the infected person during each period. Using the relations 4.2 and 4.3, we obtain the total flux due to breathing only,

    Φbreath/cough(t)δk>0N0(4πD(ttk))3/2(2(ttk))|Ωa|exp(δ24D(ttk)), (4.14)

    where tk=kΔbreath in the case of breathing and tk=kΔcough in the case of coughing. Figure 9 shows the case of periodic expulsion of viral particles, such as breathing and coughing every 5min (expelling 10000 particles each time) outdoors. Note the non-linear oscillations in particle flux, which are dampened by smaller values of the diffusion coefficient (Figure 9b). After the infectious person leaves the scene, the aerosol concentration decays exponentially.

    Figure 9.  Analytical absorbed flux for a periodic source of viral particles. Flux of particles absorbed by the susceptible person from Eq (4.14) when the infected person (a) breathes out 10 particles per minute (as a function of the inter-person distance δ and D=104m2/s); and (b) coughs every 5min, releasing 10,000 particles with each cough (for different values of the diffusion coefficient D and δ=0.5m). After 60 min, the infected person leaves the room, which leads to an exponential decay of the flux over time.

    In the combined case, when both breathing and coughing are considered, the total flux is simply the sum of the two:

    Φtotal(t,δ)=Φbreathing(t)+ΦCough(t). (4.15)

    The time to infection is the first time that the total number of particles reaches the threshold Tinf

    τinf=inf{t>0s.t.Φtotal(t)=T}. (4.16)

    Finally, we can define the probability of infection at time t for distance δ for a viral load threshold T as

    Pr{t,δ|T}=ΦTotal(t,δ)ΦTotal(T,δ). (4.17)

    In the fast-load-release approximation (i.e., coughing repeatedly at a high frequency), and by considering that most of the viral particles are expelled at the maximum of the coughing event, we can obtain a linear regime of accumulation:

    ΦCough(t)3N08πδ2|Ωa|t. (4.18)

    The authors declare that they have not used Artificial Intelligence (AI) tools in the creation of this article.

    The authors declare that there are no conflicts of interest.

    Figure S1.  Influence of the direction of air movement. The mean time to infection as a function of distance and air movement direction for an infected person coughing in a room with open windows. (a) The light-blue arrow indicates the direction of air movement/ventilation between the two windows. The direction of infection between the infected person (red circle) and the susceptible person (blue circle) can be perpendicular (left panel), parallel (middle panel) and antiparallel (right panel) to the direction of air movement. The shaded circle indicates the volume in which viral particles appear during coughing. (b) Distribution of time to infection for distances d=0.5,1,1.5,2, and 2.5 m and the scenarios: perpendicular (blue), parallel (orange), and antiparallel (green). (c) Mean infection time for the different scenarios. Missing bars indicate scenarios in which at least one realization had an infection time beyond 12 h. Error bars indicate the standard deviation of the time distribution.
    Figure S2.  Influence of the threshold number of particles required for infection in the breathing case. Mean time to infection for two different values of the threshold, 50 (blue) and 100 absorbed particles. Error bars indicate the standard deviation of the time distribution.
    Figure S3.  Plot of function 2g(x)/π. Normalized visualisation of the function g defined in Eq (4.7) in the main text. For x, g approaches a constant value of π/2.
    [1] Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676. doi: 10.1016/j.cell.2006.07.024
    [2] Takahashi K, Tanabe K, Ohnuki M, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872. doi: 10.1016/j.cell.2007.11.019
    [3] Yamanaka S (2009) Elite and stochastic models for induced pluripotent stem cell generation. Nature 460: 49-52. doi: 10.1038/nature08180
    [4] Ichida JK, Blanchard J, Lam K, et al. (2009) A small-molecule inhibitor of tgf-beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 5: 491-503. doi: 10.1016/j.stem.2009.09.012
    [5] Lin T, Ambasudhan R, Yuan X, et al. (2009) A chemical platform for improved induction of human iPSCs. Nat Methods 6: 805-808. doi: 10.1038/nmeth.1393
    [6] Maherali N, Sridharan R, Xie W, et al. (2007) Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55-70. doi: 10.1016/j.stem.2007.05.014
    [7] Kim K, Doi A, Wen B, et al. (2010) Epigenetic memory in induced pluripotent stem cells. Nature 467: 285-290. doi: 10.1038/nature09342
    [8] Carey BW, Markoulaki S, Hanna JH, et al. (2011) Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 9: 588-598. doi: 10.1016/j.stem.2011.11.003
    [9] Kawamura T, Suzuki J, Wang YV, et al. (2009) Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460: 1140-1144. doi: 10.1038/nature08311
    [10] Hong H, Takahashi K, Ichisaka T, et al. (2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460: 1132-1135. doi: 10.1038/nature08235
    [11] Li H, Collado M, Villasante A, et al. (2009) The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460: 1136-1139. doi: 10.1038/nature08290
    [12] Banito A, Rashid ST, Acosta JC, et al. (2009) Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev 23: 2134-2139. doi: 10.1101/gad.1811609
    [13] Marion RM, Strati K, Li H, et al. (2009) A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460: 1149-1153. doi: 10.1038/nature08287
    [14] Park IH, Arora N, Huo H, et al. (2008) Disease-specific induced pluripotent stem cells. Cell 134: 877-886. doi: 10.1016/j.cell.2008.07.041
    [15] Teive HA, Moro A, Moscovich M, et al. (2015) Ataxia-telangiectasia – A historical review and a proposal for a new designation: ATM syndrome. J Neurol Sci 355: 3-6. doi: 10.1016/j.jns.2015.05.022
    [16] Savitsky K, Bar-Shira A, Gilad S, et al. (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753. doi: 10.1126/science.7792600
    [17] Shiloh Y (2006) The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 31: 402-410. doi: 10.1016/j.tibs.2006.05.004
    [18] Lee JH, Paull TT (2007) Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 26: 7741-7748. doi: 10.1038/sj.onc.1210872
    [19] Nayler S, Gatei M, Kozlov S, et al. (2012) Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype. Stem Cells Transl Med 1: 523-535. doi: 10.5966/sctm.2012-0024
    [20] Lin L, Swerdel MR, Lazaropoulos MP, et al. (2015) Spontaneous ATM Gene Reversion in A-T iPSC to Produce an Isogenic Cell Line. Stem Cell Reports 5: 1097-1108. doi: 10.1016/j.stemcr.2015.10.010
    [21] Fukawatase Y, Toyoda M, Okamura K, et al. (2014) Ataxia telangiectasia derived iPS cells show preserved x-ray sensitivity and decreased chromosomal instability. Sci Rep 4: 5421.
    [22] Lee P, Martin NT, Nakamura K, et al. (2013) SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCs. Nat Commun 4: 1824. doi: 10.1038/ncomms2824
    [23] Carlessi L, Fusar Poli E, Delia D (2013) Brain and induced pluripotent stem cell-derived neural stem cells as an in vitro model of neurodegeneration in ataxia-telangiectasia. Exp Biol Med (Maywood) 238: 301-307. doi: 10.1177/1535370213480703
    [24] Kinoshita T, Nagamatsu G, Kosaka T, et al. (2011) Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells. Biochem Biophys Res Commun 407: 321-326. doi: 10.1016/j.bbrc.2011.03.013
    [25] Wen W, Zhang JP, Xu J, et al. (2016) Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors. Stem Cell Reports 6: 873-884. doi: 10.1016/j.stemcr.2016.04.005
    [26] Su RJ, Baylink DJ, Neises A, et al. (2013) Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors. PLoS One 8: e64496. doi: 10.1371/journal.pone.0064496
    [27] Chou BK, Gu H, Gao Y, et al. (2015) A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach. Stem Cells Transl Med 4: 320-332. doi: 10.5966/sctm.2014-0214
    [28] Bhatt N, Ghosh R, Roy S, et al. (2016) Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells. Stem Cell Res 17: 296-305. doi: 10.1016/j.scr.2016.08.006
    [29] Lu J, Li H, Baccei A, et al. (2016) Influence of ATM-Mediated DNA Damage Response on Genomic Variation in Human Induced Pluripotent Stem Cells. Stem Cells Dev 25: 740-747. doi: 10.1089/scd.2015.0393
    [30] Ahnesorg P, Smith P, Jackson SP (2006) XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124: 301-313. doi: 10.1016/j.cell.2005.12.031
    [31] Grawunder U, Wilm M, Wu X, et al. (1997) Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 388: 492-495. doi: 10.1038/41358
    [32] Riballo E, Critchlow SE, Teo SH, et al. (1999) Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol 9: 699-702. doi: 10.1016/S0960-9822(99)80311-X
    [33] O'Driscoll M, Cerosaletti KM, Girard PM, et al. (2001) DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 8: 1175-1185. doi: 10.1016/S1097-2765(01)00408-7
    [34] Ben-Omran TI, Cerosaletti K, Concannon P, et al. (2005) A patient with mutations in DNA Ligase IV: clinical features and overlap with Nijmegen breakage syndrome. Am J Med Genet A 137A: 283-287. doi: 10.1002/ajmg.a.30869
    [35] Tilgner K, Neganova I, Moreno-Gimeno I, et al. (2013) A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors. Cell Death Differ 20: 1089-1100. doi: 10.1038/cdd.2013.44
    [36] Felgentreff K, Du L, Weinacht KG, et al. (2014) Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells. Proc Natl Acad Sci U S A 111: 8889-8894. doi: 10.1073/pnas.1323649111
    [37] Tilgner K, Neganova I, Singhapol C, et al. (2013) Brief report: a human induced pluripotent stem cell model of cernunnos deficiency reveals an important role for XLF in the survival of the primitive hematopoietic progenitors. Stem Cells 31: 2015-2023. doi: 10.1002/stem.1456
    [38] Tischkowitz MD, Hodgson SV (2003) Fanconi anaemia. J Med Genet 40: 1-10. doi: 10.1136/jmg.40.1.1
    [39] Kutler DI, Singh B, Satagopan J, et al. (2003) A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101: 1249-1256. doi: 10.1182/blood-2002-07-2170
    [40] Moldovan GL, D'Andrea AD (2009) How the fanconi anemia pathway guards the genome. Annu Rev Genet 43: 223-249. doi: 10.1146/annurev-genet-102108-134222
    [41] Wang W (2007) Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 8: 735-748. doi: 10.1038/nrg2159
    [42] Auerbach AD, Wolman SR (1976) Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 261: 494-496. doi: 10.1038/261494a0
    [43] Raya A, Rodriguez-Piza I, Guenechea G, et al. (2009) Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460: 53-59. doi: 10.1038/nature08129
    [44] Rio P, Banos R, Lombardo A, et al. (2014) Targeted gene therapy and cell reprogramming in Fanconi anemia. EMBO Mol Med 6: 835-848. doi: 10.15252/emmm.201303374
    [45] Liu GH, Suzuki K, Li M, et al. (2014) Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat Commun 5: 4330.
    [46] Chlon TM, Hoskins EE, Mayhew CN, et al. (2014) High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells. J Virol 88: 11315-11326. doi: 10.1128/JVI.01533-14
    [47] Yung SK, Tilgner K, Ledran MH, et al. (2013) Brief report: human pluripotent stem cell models of fanconi anemia deficiency reveal an important role for fanconi anemia proteins in cellular reprogramming and survival of hematopoietic progenitors. Stem Cells 31: 1022-1029. doi: 10.1002/stem.1308
    [48] Muller LU, Milsom MD, Harris CE, et al. (2012) Overcoming Reprogramming Resistance of Fanconi Anemia Cells. Blood 119: 5449-5457. doi: 10.1182/blood-2012-02-408674
    [49] Suzuki NM, Niwa A, Yabe M, et al. (2015) Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors. Stem Cells Transl Med 4: 333-338. doi: 10.5966/sctm.2013-0172
    [50] Lee DF, Su J, Kim HS, et al. (2015) Modeling familial cancer with induced pluripotent stem cells. Cell 161: 240-254. doi: 10.1016/j.cell.2015.02.045
    [51] Yi L, Lu C, Hu W, et al. (2012) Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation. Cancer Res 72: 5635-5645. doi: 10.1158/0008-5472.CAN-12-1451
    [52] Barrett R, Ornelas L, Yeager N, et al. (2014) Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines. Stem Cells Transl Med 3: 1429-1434. doi: 10.5966/sctm.2014-0121
    [53] Hoshino H, Nagano H, Haraguchi N, et al. (2012) Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer. Int J Oncol 40: 1423-1430.
    [54] De Sandre-Giovannoli A, Bernard R, Cau P, et al. (2003) Lamin a truncation in Hutchinson-Gilford progeria. Science 300: 2055. doi: 10.1126/science.1084125
    [55] Puente XS, Quesada V, Osorio FG, et al. (2011) Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. Am J Hum Genet 88: 650-656. doi: 10.1016/j.ajhg.2011.04.010
    [56] Cabanillas R, Cadinanos J, Villameytide JA, et al. (2011) Nestor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations. Am J Med Genet A 155A: 2617-2625.
    [57] Zhang J, Lian Q, Zhu G, et al. (2011) A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8: 31-45. doi: 10.1016/j.stem.2010.12.002
    [58] Liu GH, Barkho BZ, Ruiz S, et al. (2011) Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472: 221-225. doi: 10.1038/nature09879
    [59] Ho JC, Zhou T, Lai WH, et al. (2011) Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C. Aging (Albany NY) 3: 380-390.
    [60] Nissan X, Blondel S, Navarro C, et al. (2012) Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA. Cell Rep 2: 1-9. doi: 10.1016/j.celrep.2012.05.015
    [61] Soria-Valles C, Osorio FG, Gutierrez-Fernandez A, et al. (2015) NF-kappaB activation impairs somatic cell reprogramming in ageing. Nat Cell Biol 17: 1004-1013. doi: 10.1038/ncb3207
    [62] Mason PJ, Wilson DB, Bessler M (2005) Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance. Curr Mol Med 5: 159-170. doi: 10.2174/1566524053586581
    [63] Walne AJ, Dokal I (2009) Advances in the understanding of dyskeratosis congenita. Br J Haematol 145: 164-172. doi: 10.1111/j.1365-2141.2009.07598.x
    [64] Agarwal S, Loh YH, McLoughlin EM, et al. (2010) Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464: 292-296. doi: 10.1038/nature08792
    [65] Winkler T, Hong SG, Decker JE, et al. (2013) Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs. J Clin Invest 123: 1952-1963. doi: 10.1172/JCI67146
    [66] Batista LF, Pech MF, Zhong FL, et al. (2011) Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 474: 399-402. doi: 10.1038/nature10084
    [67] Gu BW, Apicella M, Mills J, et al. (2015) Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients. PLoS One 10: e0127414. doi: 10.1371/journal.pone.0127414
    [68] Woo DH, Chen Q, Yang TL, et al. (2016) Enhancing a Wnt-Telomere Feedback Loop Restores Intestinal Stem Cell Function in a Human Organotypic Model of Dyskeratosis Congenita. Cell Stem Cell 19: 397-405. doi: 10.1016/j.stem.2016.05.024
    [69] Yu Y, Chang L, Zhao H, et al. (2015) Chromosome microduplication in somatic cells decreases the genetic stability of human reprogrammed somatic cells and results in pluripotent stem cells. Sci Rep 5: 10114. doi: 10.1038/srep10114
    [70] Bershteyn M, Hayashi Y, Desachy G, et al. (2014) Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells. Nature 507: 99-103. doi: 10.1038/nature12923
    [71] Yokota M, Hatakeyama H, Okabe S, et al. (2015) Mitochondrial respiratory dysfunction caused by a heteroplasmic mitochondrial DNA mutation blocks cellular reprogramming. Hum Mol Genet 24: 4698-4709. doi: 10.1093/hmg/ddv201
    [72] Hung SS, Van Bergen NJ, Jackson S, et al. (2016) Study of mitochondrial respiratory defects on reprogramming to human induced pluripotent stem cells. Aging (Albany NY) 8: 945-957.
    [73] Zhou Y, Al-Saaidi RA, Fernandez-Guerra P, et al. (2017) Mitochondrial Spare Respiratory Capacity Is Negatively Correlated with Nuclear Reprogramming Efficiency. Stem Cells Dev 26: 166-176. doi: 10.1089/scd.2016.0162
    [74] Nishimura K, Aizawa S, Nugroho FL, et al. (2017) A Role for KLF4 in Promoting the Metabolic Shift via TCL1 during Induced Pluripotent Stem Cell Generation. Stem Cell Reports 8: 787-801. doi: 10.1016/j.stemcr.2017.01.026
    [75] Mizuguchi Y, Hatakeyama H, Sueoka K, et al. (2017) Low dose resveratrol ameliorates mitochondrial respiratory dysfunction and enhances cellular reprogramming. Mitochondrion.
    [76] Shore EM, Xu M, Feldman GJ, et al. (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38: 525-527. doi: 10.1038/ng1783
    [77] Hamasaki M, Hashizume Y, Yamada Y, et al. (2012) Pathogenic mutation of Alk2 inhibits ips cell reprogramming and maintenance: mechanisms of reprogramming and strategy for drug identification. Stem Cells 30: 2437-2449. doi: 10.1002/stem.1221
    [78] Cai J, Orlova VV, Cai X, et al. (2015) Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva. Stem Cell Reports 5: 963-970. doi: 10.1016/j.stemcr.2015.10.020
    [79] Hildebrand L, Rossbach B, Kuhnen P, et al. (2016) Generation of integration free induced pluripotent stem cells from fibrodysplasia ossificans progressiva (FOP) patients from urine samples. Stem Cell Res 16: 54-58. doi: 10.1016/j.scr.2015.11.017
    [80] Matsumoto Y, Hayashi Y, Schlieve CR, et al. (2013) Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation. Orphanet J Rare Dis 8: 190. doi: 10.1186/1750-1172-8-190
    [81] Barruet E, Morales BM, Lwin W, et al. (2016) The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling. Stem Cell Res Ther 7: 115. doi: 10.1186/s13287-016-0372-6
    [82] Ying QL, Nichols J, Chambers I, et al. (2003) BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115: 281-292. doi: 10.1016/S0092-8674(03)00847-X
    [83] Qi X, Li TG, Hao J, et al. (2004) BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc Natl Acad Sci U S A 101: 6027-6032. doi: 10.1073/pnas.0401367101
    [84] Schuldiner M, Yanuka O, Itskovitz-Eldor J, et al. (2000) Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 97: 11307-11312. doi: 10.1073/pnas.97.21.11307
    [85] Chadwick K, Wang L, Li L, et al. (2003) Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102: 906-915. doi: 10.1182/blood-2003-03-0832
    [86] James D, Levine AJ, Besser D, et al. (2005) TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132: 1273-1282. doi: 10.1242/dev.01706
    [87] Xu RH, Peck RM, Li DS, et al. (2005) Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2: 185-190. doi: 10.1038/nmeth744
    [88] Kennedy M, D'Souza SL, Lynch-Kattman M, et al. (2007) Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 109: 2679-2687.
    [89] Samavarchi-Tehrani P, Golipour A, David L, et al. (2010) Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7: 64-77. doi: 10.1016/j.stem.2010.04.015
    [90] Hayashi Y, Hsiao EC, Sami S, et al. (2016) BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence. Proc Natl Acad Sci U S A 113: 13057-13062. doi: 10.1073/pnas.1603668113
    [91] Hatsell SJ, Idone V, Wolken DM, et al. (2015) ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Sci Transl Med 7: 303ra137.
    [92] Hino K, Ikeya M, Horigome K, et al. (2015) Neofunction of ACVR1 in fibrodysplasia ossificans progressiva. Proc Natl Acad Sci U S A 112: 15438-15443. doi: 10.1073/pnas.1510540112
    [93] Takahashi K, Yamanaka S (2016) A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol 17: 183-193.
    [94] Worringer KA, Rand TA, Hayashi Y, et al. (2014) The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes. Cell Stem Cell 14: 40-52. doi: 10.1016/j.stem.2013.11.001
    [95] Nie B, Wang H, Laurent T, et al. (2012) Cellular reprogramming: a small molecule perspective. Curr Opin Cell Biol 24: 784-792. doi: 10.1016/j.ceb.2012.08.010
    [96] Lin T, Wu S (2015) Reprogramming with Small Molecules instead of Exogenous Transcription Factors. Stem Cells Int 2015: 794632.
    [97] Baranek M, Markiewicz WT, Barciszewski J (2016) Selected small molecules as inducers of pluripotency. Acta Biochim Pol 63: 709-716. doi: 10.18388/abp.2016_1363
    [98] Hayashi Y, Chan T, Warashina M, et al. (2010) Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions. PLoS One 5: e14099. doi: 10.1371/journal.pone.0014099
    [99] Hayashi Y, Furue MK (2016) Biological Effects of Culture Substrates on Human Pluripotent Stem Cells. Stem Cells Int 2016: 5380560.
    [100] Kime C, Sakaki-Yumoto M, Goodrich L, et al. (2016) Autotaxin-mediated lipid signaling intersects with LIF and BMP signaling to promote the naive pluripotency transcription factor program. Proc Natl Acad Sci U S A 113: 12478-12483. doi: 10.1073/pnas.1608564113
    [101] Yoshida Y, Takahashi K, Okita K, et al. (2009) Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5: 237-241. doi: 10.1016/j.stem.2009.08.001
  • This article has been cited by:

    1. M Bendahmane, K H Karlsen, F Mroué, Stochastic electromechanical bidomain model * , 2024, 37, 0951-7715, 075023, 10.1088/1361-6544/ad5132
    2. Mrinmay Biswas, Ansgar Jüngel, 2025, Chapter 1, 978-981-96-3097-4, 1, 10.1007/978-981-96-3098-1_1
  • Reader Comments
  • © 2017 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(5897) PDF downloads(1084) Cited by(4)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog